Bayer Aktiengesellschaft against Moderna, Inc. — live side-by-side technical comparison.
Prices as of 2026-10-09T15:35:26+00:00 UTC · updates daily
MRNA leads 5 of the 5 windows we measure — over 1 month BAYN.DE is -11.1% and MRNA +65.9%; over year to date BAYN.DE is +18.3% and MRNA +663.0%.
| BAYN.DE | MRNA | |
|---|---|---|
| Price | $43.77 | $225.00 |
| 1 day | +2.8% | +14.2%lead |
| 5 days | -2.6% | +18.4%lead |
| 1 month | -11.1% | +65.9%lead |
| 6 months | +8.2% | +338.8%lead |
| Year to date | +18.3% | +663.0%lead |
| 52-week position | 64% of range | 100% of range |
| 52-week range | $25.78–$53.92 | $22.28–$225.00 |
| vs 50-day average | below $48.20 | above $138.26 |
| vs 200-day average | above $43.17 | above $72.63 |
| RSI (14) | 29 | 72 |
| Next earnings | 2026-11-03 | 2026-11-05 |
BAYN.DE trades at $43.77, below its 50-day average of $48.20, and above the 200-day at $43.17. It sits at 64% of its 52-week range ($25.78–$53.92); 14-day RSI is 29, in oversold territory; an average session moves it about 3.2%. For levels, the first level overhead is $45.00 (2.8% away) and the first support below is $43.17 (1.4% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.
MRNA trades at $225.00, above its 50-day average of $138.26, and above the 200-day at $72.63. It sits at 100% of its 52-week range ($22.28–$225.00); 14-day RSI is 72, in overbought territory; an average session moves it about 7.1%. For levels, the first level overhead is $250.00 (11.1% away) and the first support below is $200.00 (11.1% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.
MRNA is the more volatile of the two — an average session moves it 7.1% against 3.2% for BAYN.DE, so an identical position size carries roughly 2.2× the daily risk.
The comparison turns on those levels: BAYN.DE clearing $45.00 or losing $43.17; MRNA clearing $250.00 or losing $200.00. Until one of them gives way, the relative reading above stands.